The use of a phytotherapic compound containing tanacetum parthenium and andrographis, in combination with coq10 and riboflavin, for migraine prophylaxis: A randomized double blind versus placebo clinical trial

Authors
Category Primary study
ConferenceCephalalgia
Year 2019
This article has no abstract
Epistemonikos ID: 5858a5e1cb4a8eeee296c205c9c912cd4fe9bf57
First added on: Apr 29, 2026